Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins

FEBS Journal

Volumn 280, Issue 10, 2013, Pages 2369-2381

  Brézillon, Stéphane ^a   Pietraszek, Katarzyna ^a   Maquart, François Xavier ^a,b   Wegrowski, Yanusz ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

cancer; extracellular matrix; integrin; lumican; matrix metalloproteinases; small leucine rich proteoglycans

Indexed keywords

CHEMOKINE; CORE PROTEIN; DECORIN; GELATINASE B; GLYCOSAMINOGLYCAN; GROWTH FACTOR; INTEGRIN; LUMICAN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; PROTEOGLYCAN; VERY LATE ACTIVATION ANTIGEN 2;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CARCINOGENESIS; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLORECTAL CANCER; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; LUNG CANCER; MELANOMA; MELANOMA CELL; NONHUMAN; OSTEOSARCOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR MICROENVIRONMENT;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CHONDROITIN SULFATE PROTEOGLYCANS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FIBROBLASTS; HEK293 CELLS; HUMANS; INTEGRIN ALPHA2BETA1; KERATAN SULFATE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 9; MICE; PHYLOGENY; PROTEIN INTERACTION MAPPING;

MUS;

EID: 84877701312     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12210     Document Type: Review

References (84)

1. Hassell JR, Newsome DA, Krachmer JH, &, Rodrigues MM, (1980) Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. Proc Natl Acad Sci USA 77, 3705-3709. (Pubitemid 10012927)
2. Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, &, Tzanakakis GN, (2008) Lumican, a small leucine-rich proteoglycan. IUBMB Life 60, 818-823.
3. Iozzo RV, (1997) The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 32, 141-174. (Pubitemid 27209329)
4. Iozzo RV, (1999) The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 274, 18843-18846. (Pubitemid 29314072)
5. Funderburgh JL, Funderburgh ML, Mann MM, &, Conrad GW, (1991) Arterial lumican. Properties of a corneal-type keratan sulfate proteoglycan from bovine aorta. J Biol Chem 266, 24773-24777. (Pubitemid 21909008)
6. Schaefer L, Grone HJ, Raslik I, Robenek H, Ugorcakova J, Budny S, Schaefer RM, &, Kresse H, (2000) Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int 58, 1557-1568.
7. Dolhnikoff M, Morin J, Roughley PJ, &, Ludwig MS, (1998) Expression of lumican in human lungs. Am J Respir Cell Mol Biol 19, 582-587. (Pubitemid 128354239)
8. Leygue E, Snell L, Dotzlaw H, Hole K, Hiller-Hitchcock T, Roughley PJ, Watson PH, &, Murphy LC, (1998) Expression of lumican in human breast carcinoma. Cancer Res 58, 1348-1352. (Pubitemid 28193587)
9. Lu YP, Ishiwata T, Kawahara K, Watanabe M, Naito Z, Moriyama Y, Sugisaki Y, &, Asano G, (2002) Expression of lumican in human colorectal cancer cells. Pathol Int 52, 519-526. (Pubitemid 35279081)
10. Ping LY, Ishiwata T, &, Asano G, (2002) Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells. J Pathol 196, 324-330. (Pubitemid 34189422)
11. Raouf A, Ganss B, McMahon C, Vary C, Roughley PJ, &, Seth A, (2002) Lumican is a major proteoglycan component of the bone matrix. Matrix Biol 21, 361-367. (Pubitemid 34786472)
12. Sztrolovics R, Alini M, Mort JS, &, Roughley PJ, (1999) Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine (Phila Pa 1976) 24, 1765-1771. (Pubitemid 29426668)
13. Grover J, Chen XN, Korenberg JR, &, Roughley PJ, (1995) The human lumican gene. Organization, chromosomal location, and expression in articular cartilage. J Biol Chem 270, 21942-21949.
14. Corpuz LM, Funderburgh JL, Funderburgh ML, Bottomley GS, Prakash S, &, Conrad GW, (1996) Molecular cloning and tissue distribution of keratocan. Bovine corneal keratan sulfate proteoglycan 37A. J Biol Chem 271, 9759-9763.
15. Cornuet PK, Blochberger TC, &, Hassell JR, (1994) Molecular polymorphism of lumican during corneal development. Invest Ophthalmol Vis Sci 35, 870-877. (Pubitemid 24079817)
16. Vuillermoz B, Khoruzhenko A, D'Onofrio MF, Ramont L, Venteo L, Perreau C, Antonicelli F, Maquart FX, &, Wegrowski Y, (2004) The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res 296, 294-306. (Pubitemid 38624650)
17. Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcock T, Murphy LC, Roughley PJ, &, Watson PH, (2000) Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol 192, 313-320.
18. Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, Roughley PJ, Murphy LC, &, Watson PH, (2003) Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 9, 207-214. (Pubitemid 36109735)
19. Schaefer L, &, Iozzo RV, (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 283, 21305-21309.
20. Chakravarti S, Stallings RL, SundarRaj N, Cornuet PK, &, Hassell JR, (1995) Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. Genomics 27, 481-488.
21. McEwan PA, Scott PG, Bishop PN, &, Bella J, (2006) Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol 155, 294-305. (Pubitemid 44278663)
22. Blochberger TC, Vergnes JP, Hempel J, &, Hassell JR, (1992) cDNA to chick lumican (corneal keratan sulfate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. J Biol Chem 267, 347-352.
23. Funderburgh JL, Funderburgh ML, Brown SJ, Vergnes JP, Hassell JR, Mann MM, &, Conrad GW, (1993) Sequence and structural implications of a bovine corneal keratan sulfate proteoglycan core protein. Protein 37B represents bovine lumican and proteins 37A and 25 are unique. J Biol Chem 268, 11874-11880. (Pubitemid 23168144)
24. Funderburgh JL, Funderburgh ML, Hevelone ND, Stech ME, Justice MJ, Liu CY, Kao WW, &, Conrad GW, (1995) Sequence, molecular properties, and chromosomal mapping of mouse lumican. Invest Ophthalmol Vis Sci 36, 2296-2303.
25. Scott PG, McEwan PA, Dodd CM, Bergmann EM, Bishop PN, &, Bella J, (2004) Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc Natl Acad Sci USA 101, 15633-15638. (Pubitemid 39473539)
26. Scott PG, Dodd CM, Bergmann EM, Sheehan JK, &, Bishop PN, (2006) Crystal structure of the biglycan dimer and evidence that dimerization is essential for folding and stability of class I small leucine-rich repeat proteoglycans. J Biol Chem 281, 13324-13332. (Pubitemid 43855243)
27. Scott PG, Grossmann JG, Dodd CM, Sheehan JK, &, Bishop PN, (2003) Light and X-ray scattering show decorin to be a dimer in solution. J Biol Chem 278, 18353-18359. (Pubitemid 36799456)
28. Kajava AV, (1998) Structural diversity of leucine-rich repeat proteins. J Mol Biol 277, 519-527. (Pubitemid 28190855)
29. Kalamajski S, &, Oldberg A, (2009) Homologous sequence in lumican and fibromodulin leucine-rich repeat 5-7 competes for collagen binding. J Biol Chem 284, 534-539.
30. Kalamajski S, &, Oldberg A, (2007) Fibromodulin binds collagen type I via Glu-353 and Lys-355 in leucine-rich repeat 11. J Biol Chem 282, 26740-26745. (Pubitemid 47501936)
31. Geng Y, McQuillan D, &, Roughley PJ, (2006) SLRP interaction can protect collagen fibrils from cleavage by collagenases. Matrix Biol 25, 484-491. (Pubitemid 44751452)
32. Qin H, Ishiwata T, &, Asano G, (2001) Effects of the extracellular matrix on lumican expression in rat aortic smooth muscle cells in vitro. J Pathol 195, 604-608. (Pubitemid 34030799)
33. Matsuda Y, Yamamoto T, Kudo M, Kawahara K, Kawamoto M, Nakajima Y, Koizumi K, Nakazawa N, Ishiwata T, &, Naito Z, (2008) Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Int J Oncol 33, 1177-1185.
34. Nikitovic D, Chatzinikolaou G, Tsiaoussis J, Tsatsakis A, Karamanos NK, &, Tzanakakis GN, (2012) Insights into targeting colon cancer cell fate at the level of proteoglycans/glycosaminoglycans. Curr Med Chem 19, 4247-4258.
35. Seya T, Tanaka N, Shinji S, Yokoi K, Koizumi M, Teranishi N, Yamashita K, Tajiri T, Ishiwata T, &, Naito Z, (2006) Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis. Oncol Rep 16, 1225-1230.
36. Holland JW, Meehan KL, Redmond SL, &, Dawkins HJ, (2004) Purification of the keratan sulfate proteoglycan expressed in prostatic secretory cells and its identification as lumican. Prostate 59, 252-259. (Pubitemid 38509757)
37. Melrose J, Smith SM, Fuller ES, Young AA, Roughley PJ, Dart A, &, Little CB, (2007) Biglycan and fibromodulin fragmentation correlates with temporal and spatial annular remodelling in experimentally injured ovine intervertebral discs. Eur Spine J 16, 2193-2205. (Pubitemid 350276093)
38. Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, Oldberg A, Birk DE, &, Chakravarti S, (2002) A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol Chem 277, 35532-35540.
39. Saika S, Miyamoto T, Tanaka S, Tanaka T, Ishida I, Ohnishi Y, Ooshima A, Ishiwata T, Asano G, Chikama T, et al,. (2003) Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. Invest Ophthalmol Vis Sci 44, 2094-2102. (Pubitemid 36520304)
40. Liu CY, &, Kao WW, (2012) Lumican promotes corneal epithelial wound healing. Methods Mol Biol 836, 285-290.
41. Yeh LK, Chen WL, Li W, Espana EM, Ouyang J, Kawakita T, Kao WW, Tseng SC, &, Liu CY, (2005) Soluble lumican glycoprotein purified from human amniotic membrane promotes corneal epithelial wound healing. Invest Ophthalmol Vis Sci 46, 479-486. (Pubitemid 40270325)
42. Saika S, Shiraishi A, Liu CY, Funderburgh JL, Kao CW, Converse RL, &, Kao WW, (2000) Role of lumican in the corneal epithelium during wound healing. J Biol Chem 275, 2607-2612. (Pubitemid 30082027)
43. Seomun Y, &, Joo CK, (2008) Lumican induces human corneal epithelial cell migration and integrin expression via ERK 1/2 signaling. Biochem Biophys Res Commun 372, 221-225.
44. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, &, Carroll H, (1998) Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 141, 1277-1286. (Pubitemid 28265620)
45. Vuillermoz B, Wegrowski Y, Contet-Audonneau JL, Danoux L, Pauly G, &, Maquart FX, (2005) Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts. Mol Cell Biochem 277, 63-72. (Pubitemid 41236187)
46. Onda M, Ishiwata T, Kawahara K, Wang R, Naito Z, &, Sugisaki Y, (2002) Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis. Exp Mol Pathol 72, 142-149.
47. Fassot C, Briet M, Rostagno P, Barbry P, Perret C, Laude D, Boutouyrie P, Bozec E, Bruneval P, Latremouille C, et al,. (2008) Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease. J Hypertens 26, 747-757. (Pubitemid 351354923)
48. Ishiwata T, Yamamoto T, Kawahara K, Kawamoto Y, Matsuda Y, Ishiwata S, &, Naito Z, (2010) Enhanced expression of lumican inhibited the attachment and growth of human embryonic kidney 293 cells. Exp Mol Pathol 88, 363-370.
49. Rees SG, Dent CM, &, Caterson B, (2009) Metabolism of proteoglycans in tendon. Scand J Med Sci Sports 19, 470-478.
50. Malinowski M, Pietraszek K, Perreau C, Boguslawski M, Decot V, Stoltz JF, Vallar L, Niewiarowska J, Cierniewski CS, Maquart FX, et al,. (2012) Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14. PLoS One 7, e50709.
51. Li Y, Aoki T, Mori Y, Ahmad M, Miyamori H, Takino T, &, Sato H, (2004) Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar. Cancer Res 64, 7058-7064. (Pubitemid 39331017)
52. Mimura T, Chang JH, Kim TI, Onguchi T, Kojima T, Sakimoto T, &, Azar DT, (2011) MT1-MMP cleavage of the antiangiogenic proteoglycan decorin: role in corneal angiogenesis. Cornea 30 (Suppl 1), S45-S49.
53. Brezillon S, Venteo L, Ramont L, D'Onofrio MF, Perreau C, Pluot M, Maquart FX, &, Wegrowski Y, (2007) Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma. Clin Exp Dermatol 32, 405-416. (Pubitemid 46828334)
54. Zeltz C, Brezillon S, Kapyla J, Eble JA, Bobichon H, Terryn C, Perreau C, Franz CM, Heino J, Maquart FX, et al,. (2010) Lumican inhibits cell migration through alpha2beta1 integrin. Exp Cell Res 316, 2922-2931.
55. Brezillon S, Zeltz C, Schneider L, Terryn C, Vuillermoz B, Ramont L, Perrau C, Pluot M, Diebold MD, Radwanska A, et al,. (2009) Lumican inhibits B16F1 melanoma cell lung metastasis. J Physiol Pharmacol 60 (Suppl 4), 15-22.
56. Brezillon S, Radwanska A, Zeltz C, Malkowski A, Ploton D, Bobichon H, Perreau C, Malicka-Blaszkiewicz M, Maquart FX, &, Wegrowski Y, (2009) Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes. Cancer Lett 283, 92-100.
57. D'Onofrio MF, Brezillon S, Baranek T, Perreau C, Roughley PJ, Maquart FX, &, Wegrowski Y, (2008) Identification of beta1 integrin as mediator of melanoma cell adhesion to lumican. Biochem Biophys Res Commun 365, 266-272. (Pubitemid 350148072)
58. Zeltz C, Brezillon S, Perreau C, Ramont L, Maquart FX, &, Wegrowski Y, (2009) Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration. FEBS Lett 583, 3027-3032.
59. Sifaki M, Assouti M, Nikitovic D, Krasagakis K, Karamanos NK, &, Tzanakakis GN, (2006) Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes. IUBMB Life 58, 606-610. (Pubitemid 44527225)
60. Radwanska A, Baczynska D, Nowak D, Brezillon S, Popow A, Maquart FX, Wegrowski Y, &, Malicka-Blaszkiewicz M, (2008) Lumican affects actin cytoskeletal organization in human melanoma A375 cells. Life Sci 83, 651-660.
61. Albig AR, Roy TG, Becenti DJ, &, Schiemann WP, (2007) Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis. Angiogenesis 10, 197-216. (Pubitemid 47305204)
62. Niewiarowska J, Brezillon S, Sacewicz-Hofman I, Bednarek R, Maquart FX, Malinowski M, Wiktorska M, Wegrowski Y, &, Cierniewski CS, (2011) Lumican inhibits angiogenesis by interfering with alpha2beta1 receptor activity and downregulating MMP-14 expression. Thromb Res 128, 452-457.
63. Lee S, Bowrin K, Hamad AR, &, Chakravarti S, (2009) Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J Biol Chem 284, 23662-23669.
64. Baumann P, Zigrino P, Mauch C, Breitkreutz D, &, Nischt R, (2000) Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Br J Cancer 83, 1387-1393.
65. Koninger J, Giese T, di Mola FF, Wente MN, Esposito I, Bachem MG, Giese NA, Buchler MW, &, Friess H, (2004) Pancreatic tumor cells influence the composition of the extracellular matrix. Biochem Biophys Res Commun 322, 943-949. (Pubitemid 39164444)
66. Yamamoto T, Matsuda Y, Kawahara K, Ishiwata T, &, Naito Z, (2012) Secreted 70 kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer. Cancer Lett 320, 31-39.
67. Radwanska A, Litwin M, Nowak D, Baczynska D, Wegrowski Y, Maquart FX, &, Malicka-Blaszkiewicz M, (2012) Overexpression of lumican affects the migration of human colon cancer cells through up-regulation of gelsolin and filamentous actin reorganization. Exp Cell Res 318, 2312-2323.
68. Watanabe T, Komuro Y, Kiyomatsu T, Kanazawa T, Kazama Y, Tanaka J, Tanaka T, Yamamoto Y, Shirane M, Muto T, et al,. (2006) Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res 66, 3370-3374.
69. Coulson-Thomas VJ, Gesteira TF, Coulson-Thomas YM, Vicente CM, Tersariol IL, Nader HB, &, Toma L, (2010) Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-beta, and extracellular matrix down-regulation. Exp Cell Res 316, 3207-3226.
70. Edwards IJ, (2012) Proteoglycans in prostate cancer. Nat Rev Urol 9, 196-206.
71. Shinji S, Tajiri T, Ishiwata T, Seya T, Tanaka N, &, Naito Z, (2005) Different expression levels of lumican in human carcinoid tumor and neuroendocrine cell carcinoma. Int J Oncol 26, 873-880.
72. Nikitovic D, Berdiaki A, Zafiropoulos A, Katonis P, Tsatsakis A, Karamanos NK, &, Tzanakakis GN, (2008) Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells. FEBS J 275, 350-361.
73. Nikitovic D, Chalkiadaki G, Berdiaki A, Aggelidakis J, Katonis P, Karamanos NK, &, Tzanakakis GN, (2011) Lumican regulates osteosarcoma cell adhesion by modulating TGFbeta2 activity. Int J Biochem Cell Biol 43, 928-935.
74. Nikitovic D, Aggelidakis J, Young MF, Iozzo RV, Karamanos NK, &, Tzanakakis GN, (2012) The biology of small leucine-rich proteoglycans in bone pathophysiology. J Biol Chem 287, 33926-33933.
75. Yamaguchi Y, Mann DM, &, Ruoslahti E, (1990) Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346, 281-284.
76. Naito Z, (2005) Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth. J Nippon Med Sch 72, 137-145. (Pubitemid 40943770)
77. Gregory MS, Repp AC, Holhbaum AM, Saff RR, Marshak-Rothstein A, &, Ksander BR, (2002) Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J Immunol 169, 2727-2735. (Pubitemid 34921022)
78. Vij N, Roberts L, Joyce S, &, Chakravarti S, (2004) Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. Exp Eye Res 78, 957-971. (Pubitemid 38402204)
79. Yoshioka N, Inoue H, Nakanishi K, Oka K, Yutsudo M, Yamashita A, Hakura A, &, Nojima H, (2000) Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras. J Virol 74, 1008-1013. (Pubitemid 30036239)
80. Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, Pavao MS, Tzanakakis GN, &, Karamanos NK, (2012) Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 279, 1177-1197.
81. Goldoni S, &, Iozzo RV, (2008) Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer 123, 2473-2479.
82. Iozzo RV, &, Sanderson RD, (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 15, 1013-1031.
83. Henry SP, Takanosu M, Boyd TC, Mayne PM, Eberspaecher H, Zhou W, de Crombrugghe B, Hook M, &, Mayne R, (2001) Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family. J Biol Chem 276, 12212-12221.
84. Kao WW, Funderburgh JL, Xia Y, Liu CY, &, Conrad GW, (2006) Focus on molecules: lumican. Exp Eye Res 82, 3-4. (Pubitemid 43063391)